Friday, June 19, 2015 7:03:25 AM
Kythera Biopharmaceuticals Sued by Shareholder Over Merger Bid - (via NewsPoints Desk)
June 19, 2015
Tags: NewsPoints Kythera Allergan United States Corporate Affairs Mergers &
Acquisitions
A Kythera shareholder, filed a lawsuit in Delaware Chancery Court attempting
to block the $2.1 billion purchase of the company by Allergan.
The shareholder accused Kythera’s board of breach of fiduciary duties, arguing
that the purchase price is insufficient in light of the company's growth
prospects and that deal-protection clauses in the agreement preclude other
companies from submitting successful competing offers.
Kythera did not immediately respond to requests for a comment.
To contact the law firm on behalf of shareholders of
Kythera for more information call toll free 800.511.7037
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM